Guo Hongxiong, Xu Xiaoqin, Hu Haiyang, Zhou Ying, Yang Haitao, Qiu Tao, Fu Gengfeng, Huan Xiping
Jiangsu Provincial Center for Disease Control and Prevention, 172 Jiangsu Road, Nanjing, 210009, China.
BMC Public Health. 2015 Feb 10;15:120. doi: 10.1186/s12889-015-1489-8.
Prevalence of The transmitted HIV drug resistance (THDR) has been reported in many countries. In China, the low level THDR was found in only a few provinces. To know the transmitted HIV drug resistance in east of China, we investigated THDR during 2009-2011 in Jiangsu province of China.
Between January and August of 2009, 2010, and 2011, we consecutively collected 50, 54, 53 blood specimens respectively from qualified individuals at surveillance sentinel sites in Jiangsu province according to protocol of HIV Drug Resistance Threshold Survey (HIVDR-TS) recommended by WHO. The region of pol gene including protease and partial retro-transcriptase was amplified, sequenced and edited. Then the sequences were submitted to HIV drug resistance database to analysis transmitted HIV drug resistance mutations using Calibrated Population Resistance tool. The reference sequences of different HIV-1 subtypes were downloaded from HIV database and Genebank. The phylogenetic trees were inferred using the neighbor-joining method.
Our results show that THDR has been at low level from 2009 to 2011, only K101E and V179D mutation was detected which did not belong to the major HIV-1 drug resistance mutations. Phylogenetic analysis showed that CRF01_AE is the predominant subtype, and followed by CRF07_BC and B subtype. Subtype B consists of the two distinct clusters.
The low level of THDR suggests that anti-retroviral treatment was implemented more effectively and THDR surveillance should be conducted two years later in Jiangsu province of China. CRF01_AE has become the predominant subtype and dual infection of HIV may be common in Jiangsu province.
许多国家都报告了传播性HIV耐药(THDR)的流行情况。在中国,仅在少数省份发现了低水平的THDR。为了解中国东部地区的传播性HIV耐药情况,我们于2009年至2011年期间对中国江苏省的THDR进行了调查。
在2009年、2010年和2011年的1月至8月期间,我们按照世界卫生组织推荐的HIV耐药阈值调查(HIVDR-TS)方案,分别从江苏省监测哨点的合格个体中连续收集了50份、54份和53份血液标本。对包括蛋白酶和部分逆转录酶的pol基因区域进行扩增、测序和编辑。然后将序列提交至HIV耐药数据库,使用校准人群耐药工具分析传播性HIV耐药突变。从HIV数据库和基因库下载不同HIV-1亚型的参考序列。使用邻接法推断系统发育树。
我们的结果表明,2009年至2011年期间THDR一直处于低水平,仅检测到K101E和V179D突变,这些突变不属于主要的HIV-1耐药突变。系统发育分析表明,CRF01_AE是主要亚型,其次是CRF07_BC和B亚型。B亚型由两个不同的簇组成。
THDR水平较低表明抗逆转录病毒治疗实施得更为有效,中国江苏省应在两年后进行THDR监测。CRF01_AE已成为主要亚型,HIV双重感染在江苏省可能较为常见。